Clinical Trial Update: Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER [Phase 2]

View source ↗

Summary

This Phase 2 trial update notes ongoing recruitment for adjuvant therapies targeting POLE-mutated and p53-wildtype/NSMP early-stage endometrial cancer as part o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Endometrial Cancer | Phase 2 | Status: RECRUITING